dr. michael rotkowitz on dabrafenib and trametinib combination side effects
Published 12 years ago • 1K plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:27
dr. weber on side effects of dabrafenib/trametinib in melanoma
-
4:36
practical experience with dabrafenib/trametinib in ncslc
-
1:12
dr. michael rotkowitz defines personalized medicine
-
1:32
dr. antoni ribas on the benefits of mapk inhibition with dabrafenib and trametinib
-
1:08
dr. michael rotkowitz on ipilimumab plus dacarbazine for metastatic melanoma
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
1:08
dr. rotkowitz describes challenges facing immunotherapy
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
0:57
dr. postow discusses side effects with combinations in melanoma
-
1:37
dr. arkenau on dabrafenib combined with trametinib for braf-mutated melanoma
-
1:25
dr. michael rotkowitz on dacarbazine plus ipilimumab in patients with metastatic melanoma